Insider Trading & Ownership - Ellison Mark Jason Heath

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ellison Mark Jason Heath
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-27
Sale
2023-01-31
4:21 pm
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
610$20.26$12,35918,751
(Direct)
View
2023-01-09
Sale
2023-01-09
5:13 pm
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
469$20.2$9,47419,361
(Direct)
View
2023-01-05
Sale
2023-01-05
5:07 pm
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
1,806$20.2$36,48119,830
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-03-02
Disposition
2023-03-03
09:16 am
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
30,431$200
(Direct)
View
2023-03-02
Option Award
2023-03-03
09:16 am
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
2,000$00
(Direct)
View
2023-03-02
Disposition
2023-03-03
09:16 am
2019-02-03
2029-01-02
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
26,200$00
(Direct)
View
2022-06-27
Option Award
2022-06-29
4:07 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
2,000$021,636
(Direct)
View
2022-01-04
Option Award
2022-01-05
4:19 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
12,000$019,636
(Direct)
View
2021-01-26
Option Award
2021-01-27
4:17 pm
N/A
2031-01-26
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
18,386$018,386
(Direct)
View
2020-01-07
Option Award
2020-01-09
4:09 pm
N/A
2030-01-07
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
UK Managing Director
Director
12,400$017,930
(Direct)
View